Please login to the form below
Ascletis
This page shows the latest Ascletis news and features for those working in and with pharma, biotech and healthcare.
Chinese biotechs aim PD-L1 antibody at hepatitis B
viral diseases to Ascletis in China, potentially opening up a new revenue stream for the drug. ... Under the terms of the deal, Ascletis has agreed to pay an undisclosed upfront cash fee, plus milestones and royalties on any future sales in return for
Latest news
-
Roche invests in diagnostics in China
Roche has made other investments in China in recent years including a collaboration with Chinese-American biotech company Ascletis to help bring its hepatitis C virus (HCV) therapy danoprevir to market
-
Roche taps local expertise for hep C drug in China
Many of these are infected with HCV genotype 1b, a strain which has proved "highly responsive" to danoprevir, according to Ascletis. ... Commenting on the link-up with Ascletis, Luke Miels, head of Roche's Asia-Pacific pharma operations, said: "our
More from news
Approximately 2 fully matching, plus 1 partially matching documents found.
Latest Intelligence
-
Is China ready for a pharmaceutical gold rush?
The first company to list, Ascletis Pharma Inc, was valued at $2bn when its IPO closed on 1 August. ... While some might have seen Ascletis’ fate as a market correction to the biotech stock hype, further IPOs don’t seem to be falling into line.
More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- FREELANCE Medical Writer, Senior Medical Writer, Principal Medic...
-
Highly Competitive Day Rate, Bonus &Benefits
- Senior Leadership Role – Medical Communications – North West
-
Highly Competitive Salary, Bonus &Benefits
-
Account Management
-
Competitive Salary Offered
- Freelance Medical Writer - Creative Healthcare Comms - 2 month t...
-
Excellent Day Rate
- Senior Content Editor - Biotechnology
-
Salary TBC
- Senior Account / Programme Manager - MedComms - Buckinghamshire
-
Highly Competitive Remuneration packages
-
Principal Medical Writer
-
Varies on experience
- Freelance Account Manager - Creative Healthcare Comms - Immediat...
-
Excellent Day Rate
- Pfizer helps fund biotech venture from former researchers at closed Kent facility
- Oxford University to investigate nasal spray delivery of AZ-partnered COVID-19 vaccine
- First dose of Pfizer/BioNTech vaccine reduces COVID-19 infection risk by 70%
- Bayer’s finerenone scores FDA priority review for chronic kidney disease
- New restrictions for AZ/Oxford COVID-19 vaccine despite EMA endorsement
- Moderna launches COVID-19 vaccine booster study to address new variants
- WHITE PAPER: Why do men die younger?
- Opdivo improves survival in oesophageal cancer
- Opdivo plus chemotherapy increases response in pre-surgery NSCLC patients
- UPDATE: AZ/Oxford University COVID-19 vaccine gets EU approval
- Sanofi pays $160m upfront to acquire Tidal Therapeutics
- Roche, Regeneron’s COVID-19 antibody cocktail cuts infection risk
PMHub
Cuttsy + Cuttsy
How do you understand what patients really need, without actually living their lives? How do you walk in someone else’s...
Latest intelligence
- WHITE PAPER: Why do men die younger?
- It’s a commonly accepted fact that women outlive men. Wherever you live, there’s a good chance that men will die on average eight years earlier than women. Is this an...
- 3 tips to show patient diversity in your clinical trial materials
- Here are some useful tips to help get your hands on authentically diverse stock photos....
- Virtual congresses: video thrilled the cardio tsar
- Chris Ross explores the key learnings from a year of virtual congresses...
Quick links
Infographics
